Influence of Age on the Pharmacokinetics of Alfentanil

[1]  M. Goldberg,et al.  Inhibition of alfentanil metabolism by erythromycin , 1989, Clinical pharmacology and therapeutics.

[2]  A. Burm,et al.  Age Has No Effect on the Pharmacodynamics of Alfentanil , 1988, Anesthesia and analgesia.

[3]  Donald R. Stanski,et al.  Comparison of a Computer‐assisted Infusion Versus Intermittent Bolus Administration of Alfentanil as a Supplement to Nitrous Oxide for Lower Abdominal Surgery , 1988, Anesthesiology.

[4]  D R Stanski,et al.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. , 1987, The Journal of pharmacology and experimental therapeutics.

[5]  J. Heykants,et al.  Alfentanil kinetics in the elderly , 1984, Clinical pharmacology and therapeutics.

[6]  D. Greenblatt,et al.  Effect of Age, Gender, and Obesity on Midazolam Kinetics , 1984, Anesthesiology.

[7]  L. Mather.  Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives , 1983, Clinical pharmacokinetics.

[8]  P. Sebel,et al.  The Pharmacokinetics of Alfentanil (R39209): A New Opioid Analgesic , 1982, Anesthesiology.

[9]  J S Harmatz,et al.  Diazepam disposition determinants , 1980, Clinical pharmacology and therapeutics.

[10]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[11]  J. Wagner.  A safe method for rapidly achieving plasma concentration plateaus , 1974, Clinical pharmacology and therapeutics.

[12]  D R Stanski,et al.  Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. , 1987, Anesthesiology.